Evidences have shown that fructose-1,6-bisphosphatase-2 (FBP2), a key enzyme for gluconeogenesis, was decreased in various human cells, such as cervical cancer and soft tissue sarcomas [18, 24, 25]. This evidence concerns the gene FBP2 and cervical carcinoma.